Biodexa Pharmaceuticals American Depositary Shs (BDRX) vs Endovia Health Sciences (EDVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Endovia Health Sciences is the larger company by market cap ($1.7 million vs $1.0 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDRX | EDVA |
|---|---|---|
| Share price | $0.46 | $0.1516 |
| Market cap | $1.01M | $1.68M |
| 1-day change | -11.94% | -5.19% |
| P/E ratio (TTM) | 0.01 | — |
| EPS (TTM) | $63.74 | $-21.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $52.05 | $13.40 |
| 52-week low | $0.4535 | $0.15 |
| Distance from 52-week high | -99.12% | -98.87% |
| Analyst consensus | none | — |
| Avg. price target upside | +1836.96% | — |
| Average volume | 3.72M | 4.50M |
| Shares outstanding | 2.20M | 11.08M |
| Employees | 11 | 1 |
| Sector | Health Care | Consumer Staples |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Biodexa Pharmaceuticals American Depositary Shs in Health Care and Endovia Health Sciences in Consumer Staples.
About Biodexa Pharmaceuticals American Depositary Shs
BDRX stock →Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees
About Endovia Health Sciences
EDVA stock →Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America.
Consumer Staples · Beverages (Production/Distribution) · 1 employees
BDRX vs EDVA FAQ
Which is bigger, Biodexa Pharmaceuticals American Depositary Shs or Endovia Health Sciences?
Endovia Health Sciences (EDVA) is larger, with a market capitalization of $1.68M compared with $1.01M for Biodexa Pharmaceuticals American Depositary Shs (BDRX).
Are Biodexa Pharmaceuticals American Depositary Shs and Endovia Health Sciences in the same industry?
No. Biodexa Pharmaceuticals American Depositary Shs is in the Health Care sector, while Endovia Health Sciences is in Consumer Staples.